Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-21

Clinical Trial Update: Effect of Nigella Sativa in Atorvastatin Treated Hyperlipidaemia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of Nigella sativa in patients with hyperlipidemia already treated with atorvastatin; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nigella Sativa (Nigella sativa)
  • atorvastatin (atorvastatin)

Snippet

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | Conditions: Hyperlipidemia | Phase 2 | Status: RECRUITING